IFAM
PTCT icon

Institutional & Family Asset Management’s PTC Therapeutics PTCT Stock Holding History

Institutional & Family Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11
Closed -$1K – 997
2021
Q1 		$1K Sell
11
-7
-39% -$416 ﹤0.01% 892
2020
Q4 		$1K Sell
18
-1
-5% -$59 ﹤0.01% 850
2020
Q3 		$1K Hold
19
– – ﹤0.01% 805
2020
Q2 		$1K Sell
19
-6
-24% -$295 ﹤0.01% 795
2020
Q1 		$1K Buy
+25
New +$1.26K ﹤0.01% 764

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Institutional & Family Asset Management's PTCT Position: Q2 2021 in Review

Institutional & Family Asset Management sold out of PTC Therapeutics (PTCT) in Q2 2021, closing a stake of 11 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in PTCT in Q1 2020 and held it in 5 quarters. The position peaked at $1K in Q1 2021. 182 funds tracked by Wall St. Rank hold PTCT as of Q2 2021.

  • Institutional & Family Asset Management reported no remaining PTC Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Institutional & Family Asset Management sold 11 PTC Therapeutics shares in Q2 2021, an estimated $1K.
  • Institutional & Family Asset Management first reported a position in PTC Therapeutics in Q1 2020 and held it in 5 quarters.
  • Institutional & Family Asset Management's PTC Therapeutics position peaked at $1K in Q1 2021.
  • 182 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2021.

Based on Institutional & Family Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.